JULIA HARPER: Open Payments
NPI 1457139990 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 35 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $684 · 2025 $754
Food & beverage: $654Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $147 |
| SHIELD THERAPEUTICS INC | 6 | $133 |
| Sage Therapeutics, LLC | 6 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
| Exeltis, USA Inc. | 4 | $72 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $47 |
| Hologic Sales and Service, LLC | 1 | $32 |
| MILLICENT US INC | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: ACCRUFER, ZURZUVAE, Mirena, SLYND, MYFEMBREE, Veozah, NOVASURE, Lynkuet.
Industry payments across KY — which companies pay providers there.
